Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

Comment by antisenseon Sep 30, 2022 10:36am
355 Views
Post# 34997412

RE:RE:VITALIZE Update!!??

RE:RE:VITALIZE Update!!??I hope you are right.  They lead investors to beleive the first round of early results would be released end of Q3 2022 in their:

Second Quarter 2022 Financial and Operational Results


"Selected Upcoming Milestones

Maveropepimut-S (MVP-S)

  • Q3 2022: First results on early patients in VITALIZE study in r/r DLBCL"
So they did a little shadiness here...


bikkel78 wrote:

IMV is announcing that they will present the data in a scientific conference early 2023 which is to be seen as a positive news. 

Unfortunately these conferences do not accept presentations with data that were previously communicated publicly.

In early October a new round of IR meetings will take place across Europe and I'm pretty sure bits of data will be released to that audience. 



<< Previous
Bullboard Posts
Next >>